# Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis

> **NCT03028467** · PHASE1,PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 15 (actual)

## Conditions studied

- Arthritis, Rheumatoid

## Interventions

- **DRUG:** GSK3196165 Dose 1
- **DRUG:** GSK3196165 Dose 2
- **DRUG:** GSK3196165 Dose 3
- **DRUG:** Methotrexate
- **DRUG:** Placebo
- **DRUG:** Folic acid

## Key facts

- **NCT ID:** NCT03028467
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-24
- **Primary completion:** 2017-12-20
- **Final completion:** 2017-12-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028467, "Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03028467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*